局部药物输送的全球市场规模、份额和成长分析：按类型、按应用分类 - 产业预测（2023-2030）

Global Topical Drug Delivery Market Size, Share, Growth Analysis, By Type(Topical Drug Delivery, Inhalation Drug Delivery), By Application(Cardiovascular Diseases, Respiratory Diseases) - Industry Forecast 2023-2030

出版日期: 2023年10月13日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年全球局部给药市场规模为960亿美元，预计将从2022年的1024.3亿美元增至2030年的1720.9亿美元，年复合成长率预计将增长6.7%。

近年来，市场呈现显着成长，预计将继续稳定扩张。痤疮、牛皮癣、湿疹和皮肤炎等疾病需要有效且有针对性的药物输送到受影响的区域。这些皮肤病的盛行率不断增加，以及对改进治疗方案的需求不断增长，刺激了局部给药系统的采用。此外，世界人口高龄化也促进了市场扩张。随着高龄化，关节炎、神经病变疼痛和糖尿病溃疡等慢性疾病的盛行率增加。局部给药为治疗这些疾病、促进创伤治疗和缓解疼痛提供了一种方便、非侵入性的方法。老年人不断增长的医疗需求正在推动对先进局部给药系统的需求。局部给药在输送活性成分（如类类视色素A和透明质酸）以改善皮肤外观和对抗老化征兆方面发挥重要作用。美容皮肤科的日益普及正在刺激创新的局部给药技术的开发和采用。

全球局部给药市场的区域考察

全球市场最主要的地区是北美。北美拥有发达的医疗基础设施、先进的研究设施，且慢性病盛行率较高，对局部给药系统的需求不断增加。该地区的特点是製药公司众多，并开展了广泛的以创新药物输送技术为重点的研发活动。此外，积极主动的政府配合措施、强有力的报销政策以及先进医疗技术的高采用率也有助于北美在全球市场上占据主导地位。

全球局部药物传输市场动态

全球局部给药市场的驱动因素

方便、非侵入性

局部给药提供了一种方便、非侵入性的给药方法，并且无需注射或口服药物。此功能对于害怕针头或喜欢更舒适、无麻烦的方法的患者特别有益。局部製剂的使用可以提高治疗医嘱遵从性和整体患者体验，使其成为首选，特别是对于儿童和有针恐惧症的患者。

全球局部给药市场的抑制因素

配方挑战

开发稳定有效的外用製剂面临重大挑战。药物溶解度、稳定性、与赋形剂的相容性以及实现所需释放曲线等各种因素导致製剂开发的复杂性。这些配方挑战可能会影响外用药物的可得性和商业性可行性，因为配方必须满足严格的品质标准和法规要求，同时确保最佳治疗效果。

全球给药市场趋势

老年族群的皮肤病：皮肤病患病率的增加、老年人口的增加以及对非侵入性给药方法的需求不断增长正在推动市场的发展。此外，微针和奈米载体等新的局部药物传输技术的开发也有望促进市场成长。然而，局部给药产品的高价格和严格的法规要求可能会抑制市场成长。

本报告针对全球局部给药市场进行研究与分析，提供市场动态与前景、细分市场分析、公司简介等。

Johnson & Johnson (US)
Novartis AG (Switzerland)
GlaxoSmithKline plc (United Kingdom)
Pfizer Inc. (US)
Bayer AG (Germany)
Sanofi SA (France)
Merck & Co., Inc. (US)
Eli Lilly and Company (US)
AstraZeneca PLC (United Kingdom)
Gilead Sciences, Inc. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Sun Pharmaceutical Industries Ltd. (India)
LEO Pharma A/S (Denmark)
Perrigo Company plc (Ireland)
Mylan NV (US)
Galderma SA (Switzerland)
Glenmark Pharmaceuticals Ltd. (India)
Almirall, SA (Spain)
Dermira, Inc. (US)
Fougera Pharmaceuticals Inc. (US)

简介目录

Product Code: SQMIG35D2106

Global Topical Drug Delivery Market size was valued at USD 96 billion in 2021 and is poised to grow from USD 102.43 billion in 2022 to USD 172.09 billion by 2030, growing at a CAGR of 6.7% in the forecast period (2023-2030).

The global topical drug delivery market has experienced significant growth in recent years and is expected to continue expanding at a steady pace. Conditions like acne, psoriasis, eczema, and dermatitis require effective and targeted drug delivery to the affected areas. The rising incidence of these skin ailments, coupled with the growing demand for improved treatment options, has fueled the adoption of topical drug delivery systems. Moreover, the ageing population worldwide has contributed to the market expansion. As individuals age, the prevalence of chronic conditions such as arthritis, neuropathic pain, and diabetic ulcers increases. Topical drug delivery offers a non-invasive and convenient approach for managing these conditions, promoting wound healing, and providing pain relief. The elderly population's rising healthcare needs have driven the demand for advanced topical drug delivery systems. Topical drug delivery plays a crucial role in delivering active ingredients, such as retinoids and hyaluronic acid, to enhance skin appearance and combat ageing signs. The growing popularity of cosmetic dermatology has fueled the development and adoption of innovative topical drug delivery technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Topical Drug Delivery Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Drug Delivery Market Segmental Analysis

The global topical drug delivery market is segmented by type, application, and region. Based on type, the market can be segmented into Topical Drug Delivery, Inhalation Drug Delivery, Injectable Drug Delivery, and Oral Drug Delivery. Based on application, the market is segmented Cardiovascular Diseases, Respiratory Diseases, Diabetes, Oncology, and Central Nervous System (CNS) Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Topical Drug Delivery Market Regional Insights

In the global topical drug delivery market, the most dominant region is North America. North America has a well-established healthcare infrastructure, advanced research facilities, and a high prevalence of chronic diseases, driving the demand for topical drug delivery systems. The region is characterised by a strong presence of pharmaceutical companies and extensive R&D activities focused on innovative drug delivery technologies. Additionally, favourable government initiatives, robust reimbursement policies, and a high adoption rate of advanced healthcare technologies contribute to the dominance of North America in the global topical drug delivery market.

Global Topical Drug Delivery Market Dynamics

Drivers of the Global Topical Drug Delivery Market

Convenience and Non-Invasiveness

Topical drug delivery offers a convenient and non-invasive method of administering medications, eliminating the requirement for injections or oral medications. This feature is particularly advantageous for patients who may have a fear of needles or prefer a more comfortable and hassle-free approach. The use of topical formulations enhances treatment adherence and overall patient experience, making it a preferred option, especially for children and individuals with needle phobia.

Restraints In the Global Topical Drug Delivery Market

Formulation Challenges

The development of stable and effective topical formulations can present significant challenges. Various factors, including drug solubility, stability, compatibility with excipients, and achieving the desired release profile, contribute to the complexity of formulation development. These formulation challenges can impact the availability and commercial viability of topical drug products, as the formulation must meet stringent quality standards and regulatory requirements while ensuring optimal therapeutic efficacy.

Market Trends of the Global Topical Drug Delivery Key

Skin Issues among the Aging Population: The market is driven by the increasing prevalence of skin diseases, the rising ageing population, and the growing demand for non-invasive drug delivery methods. The development of new topical drug delivery technologies, such as microneedles and nanocarriers, is also expected to boost the market growth. However, the high cost of topical drug delivery products and the stringent regulatory requirements could restrain the market growth.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Topical Drug Delivery Market by Type
- Market Overview
- Topical Drug Delivery
- Inhalation Drug Delivery
- Injectable Drug Delivery and Oral Drug Delivery.
Global Topical Drug Delivery Market by Application
- Market Overview
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes
- Oncology and Central Nervous System (CNS) Disorders.
Global Topical Drug Delivery Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Johnson & Johnson (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novartis AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlaxoSmithKline plc (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Pfizer Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bayer AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck & Co., Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eli Lilly and Company (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca PLC (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Gilead Sciences, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sun Pharmaceutical Industries Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LEO Pharma A/S (Denmark)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Perrigo Company plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Mylan N.V. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galderma S.A. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Glenmark Pharmaceuticals Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Almirall, S.A. (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Dermira, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Fougera Pharmaceuticals Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments